Related by context. All words. (Click for frequent words.) 73 COPAXONE R 73 teriflunomide 73 CIMZIA ™ 72 relapsed MM 72 riociguat 72 CIMZIA TM 72 ACTEMRA TM 72 RoACTEMRA 71 ARCOXIA 71 Betaferon R 71 Traficet EN 71 alemtuzumab treated 71 HuMax EGFr 71 oral rivaroxaban 70 INCB# [001] 70 canakinumab 70 CTAP# Capsules 70 Natalizumab 70 relapsing remitting MS RRMS 70 novel VDA molecule 70 tipranavir 70 YONDELIS 70 Catena ® 70 thetreatment 70 AZILECT R 70 ARIXTRA 69 favorable pharmacokinetic profile 69 BARACLUDE ® 69 AZILECT ® 69 PROCHYMAL 69 reduce serum phosphate 69 hyperphenylalaninemia HPA due 69 forodesine 69 sorafenib tablets 69 Vandetanib 69 STRIDE PD 69 ProSavin 69 tanespimycin 69 RRMS patients 69 Azedra 69 CYT# potent vascular disrupting 69 relapsed SCLC 69 ADAGIO study 69 OHR/AVR# 68 APTIVUS R 68 dosing cohort 68 alvimopan 68 viral kinetics 68 radezolid 68 APTIVUS 68 ibandronate 68 APTIVUS r 68 vidofludimus 68 Golimumab 68 XIENCE V PROMUS Stent 68 MAGE A3 ASCI 68 sunitinib malate 68 PREZISTA r 68 MYCAMINE 68 Oral Fingolimod 68 PROMACTA 68 diabetic neuropathic pain 68 adult chronic ITP 68 Tasimelteon 68 r hGH 68 ACZ# 68 COPAXONE ® 68 DASISION 68 colesevelam HCl 68 Archexin 68 GAMMAGARD 68 Cimzia TM 68 Tarceva TM 68 rilonacept 68 Ophena TM 68 Tavocept 68 certolizumab 68 RECORD1 68 renal toxicity 68 IRESSA 68 INVEGA ® 68 tocilizumab 68 SNT MC# 67 velafermin 67 FASLODEX 67 complete cytogenetic response 67 oral ridaforolimus 67 #mg BID [001] 67 clevidipine 67 rosuvastatin #mg 67 CIMZIA TM certolizumab pegol 67 safinamide 67 octreotide LAR 67 Forodesine HCl 67 ATL/TV# 67 UPLYSO 67 Diabetic Macular Edema 67 ATACAND 67 recurrent glioblastoma multiforme 67 RAPTIVA 67 MoxDuo TM IR 67 Azilect ® 67 Xanafide 67 evaluating tivozanib 67 CoFactor 67 BARACLUDE R 67 Certican 67 HIV HCV coinfected 67 ZOLINZA 67 brivaracetam 67 prucalopride 67 BCIRG 67 interferon beta therapy 67 cystinosis patients 67 Cimzia ® certolizumab pegol 67 ARIKACE 67 Bezielle 67 Phase IIIb clinical 67 trastuzumab Herceptin ® 67 Meets Primary Endpoint 67 MERLIN TIMI 67 pioglitazone HCl 67 PROSTVAC TM 67 FROVA 67 invasive candidiasis 67 Durezol 67 antiviral efficacy 67 TYKERB 67 alvespimycin 67 LY# [003] 67 AVONEX ® 67 CR# vcMMAE 67 sargramostim 67 Lantus ® 67 atherothrombotic events 67 PRTX 67 Phase Ib clinical 67 dose cohort 67 recurrent genital herpes 67 KRAS status 67 cilostazol 67 R#/MEM # 66 laquinimod 66 AA Amyloidosis 66 Combination REOLYSIN R 66 non metastatic osteosarcoma 66 bardoxolone methyl 66 posaconazole 66 ORENCIA ® 66 azilsartan medoxomil 66 Dasatinib 66 oral prodrug 66 solithromycin 66 Betaferon ® 66 PEGylated interferon beta 1a 66 crizotinib PF # 66 EDARBI 66 KRAS mutations occur 66 Phenoptin 66 IOP lowering 66 hour bronchodilation 66 phase IIb study 66 REMINYL ® 66 GFT# 66 aclidinium 66 tolerability profiles 66 sustained virologic response 66 Raptiva ® 66 glatiramer acetate 66 treatment naive genotype 66 Ocrelizumab 66 RE LY ® 66 K ras mutations 66 pharmacodynamic properties 66 pain palliation 66 Pegasys plus Copegus 66 Cethromycin 66 HoFH 66 elotuzumab 66 Elagolix 66 TG MV 66 Onbrez Breezhaler 66 achieved ACR# 66 metaglidasen 66 Arranon 66 EchoCRT 66 Zavesca ® 66 ACAPODENE 66 Alemtuzumab 66 ISENTRESS 66 PASI scores 66 candesartan cilexetil 66 Aptivus ® 66 RAPAFLO R 66 dosage regimens 66 Prostate AdenoCarcinoma Treatment 66 BENICAR HCT 66 REVIVE TA 66 INCB# [003] 66 Mg Usa 66 clobazam 66 HCV RESPOND 2 66 maximally tolerated dose 66 NNT = 66 SNT-MC#/idebenone 66 Cipralex ® 66 genotypic resistance 66 Elocalcitol 66 Protelos 66 DOXIL 66 Fibrillex TM 66 Tanespimycin 66 nitazoxanide 66 oral Xeloda 66 tolvaptan 66 protease inhibitor PI 66 #mg dose [002] 66 AGILECT R 66 salmeterol fluticasone 66 Pivotal Phase III 66 Ceplene/IL-2 66 rasagiline tablets 66 placebo controlled clinical 66 ritonavir boosted 66 PRT# 66 pomalidomide 66 Femara letrozole 66 HeFH 66 Fabry Disease 66 CCR9 antagonist 66 MoxDuo IR 66 desvenlafaxine succinate 66 icatibant 66 Virulizin ® 66 QNEXA 66 axitinib 66 Laquinimod 66 treatment naïve genotype 66 LymphoStat B belimumab 66 lumiliximab 66 HQK 66 lenalidomide Revlimid R 66 Cardiotoxicity 66 VELCADE melphalan 66 CALGB # [002] 66 intravascular hemolysis 66 LEXIVA r 66 oral antidiabetic medication 66 CAELYX 66 erlotinib Tarceva ® 66 oxycodone CR 66 Telbivudine 66 HCV SPRINT 66 ganetespib 66 Rebif ® 66 dose escalation phase 66 Vidofludimus 66 delafloxacin 66 Serdolect ® 65 nucleotide analog 65 metastatic neuroendocrine tumors 65 Xelox 65 HBeAg seroconversion 65 Cariprazine 65 LUX Lung 65 MICARDIS ® 65 tipranavir r 65 NEVO ™ 65 abacavir lamivudine 65 inhibitor RG# 65 Increlex ® 65 Firazyr 65 Lupuzor ™ 65 saquinavir ritonavir 65 NO# [002] 65 deferiprone 65 perampanel 65 Arikace 65 BOLDER II 65 Perforomist ™ Inhalation Solution 65 dosing cohorts 65 TMC# r 65 Hsp# Inhibitor 65 Peginterferon 65 CaPre TM 65 rufinamide 65 reslizumab 65 adalimumab Humira 65 XGEVA 65 interferon gamma 1b 65 placebo controlled Phase III 65 ARB telmisartan 65 Tipranavir 65 elacytarabine 65 ASSERT trial 65 pertuzumab 65 Multaq R 65 CANCIDAS 65 lucinactant 65 phase Ib 65 angiographic outcomes 65 ToGA 65 efalizumab 65 Prospective Randomized 65 Moxifloxacin 65 bendamustine 65 tesofensine 65 Fulvestrant 65 doripenem 65 tamoxifen Nolvadex ® 65 HBeAg positive patients 65 BRIM2 65 Interferon beta 1b 65 standard chemotherapy regimen 65 morphometric vertebral fractures 65 pan HDAC inhibitor 65 Kepivance 65 BRIM3 65 ularitide 65 SPIRIT IV 65 chronic HCV infection 65 huN# DM1 65 LT NS# 65 TEMODAL 65 Pivotal Phase 65 rheumatoid arthritis osteoarthritis ankylosing 65 SABCS 65 oxymorphone ER 65 omega interferon 65 Plicera 65 paricalcitol 65 probiotic supplementation 65 ARIMIDEX 65 AIR2 Trial 65 ULORIC 65 Cimzia ® 65 AEGR 65 pyridostigmine 65 Safinamide 65 ARIXTRA R 65 somatostatin analog 65 convenient dosing regimens 65 Hepatocellular Carcinoma HCC 65 Phase Ib study 65 INVANZ 65 blood phenylalanine Phe 65 AVANDIA 65 eltrombopag 65 Aflibercept 65 SJIA 65 Noxafil 65 INC# 65 iPrEx study 65 rimonabant #mg 65 Sapacitabine 65 NATRECOR R 65 Tesmilifene 65 cannabinor 65 inhaled iloprost 65 edoxaban 65 Pemetrexed 65 Amrubicin 65 IFN alfa 65 desvenlafaxine 65 ORENCIA R 65 evaluating mipomersen 65 Zoraxel 65 olanzapine LAI 65 salmeterol fluticasone propionate 65 Microplasmin 65 INTEGRILIN R 65 Symadex 65 catheter occlusion 65 COPAXONE R glatiramer acetate 65 PD LID 65 Tocilizumab 65 sitaxsentan 65 postmenopausal osteoporotic women 65 tapentadol ER 65 FOLPI 65 Non inferiority 65 TDF FTC 65 CCX# 65 phase IIa 65 galiximab 65 serum aminotransferase levels 65 LIALDA 65 TYGACIL 65 aldosterone antagonists 65 neratinib 65 GSK# [001] 65 Aplidin 65 eprotirome 65 TAXUS Stent 65 ZD# [001] 65 Neupro R 65 FTY# 65 Ambrisentan 65 HORIZONS AMI trial 65 PegIFN RBV 65 bosentan 65 selective modulator 65 SYMBICORT pMDI 65 mertansine 65 TRO# 65 Eltrombopag 65 evaluating REVLIMID 65 PRADAXA 65 Interferon beta 1a 65 HBV infections 65 histone deacetylase HDAC inhibitor 65 Phase 2b Clinical Trial 64 preclinical efficacy 64 iclaprim 64 virological response 64 phase IIb trial 64 neutropenia dehydration dyspnea 64 zoledronate 64 Randomized Phase 64 unresectable HCC 64 prospectively defined 64 ANAVEX #-# [001] 64 diarrhea predominant irritable 64 eplerenone 64 GW# [003] 64 QVAR ® 64 pitavastatin 64 XL# SAR# 64 antiretroviral naive 64 Pharmacokinetic 64 evaluable subjects 64 serum urate levels 64 lacosamide 64 briakinumab 64 MS relapses 64 venous thromboembolic events 64 APPRAISE 64 APOPTONE 64 dirucotide MBP# 64 ximelagatran 64 docetaxel Taxotere ® 64 TroVax ® 64 bexarotene 64 imipenem 64 REYATAZ R 64 recurrent metastatic 64 Pharmacokinetics PK 64 Hematologic 64 Fingolimod 64 receptor tyrosine kinase inhibitor 64 quetiapine fumarate 64 Zemplar Capsules 64 lenalidomide dexamethasone 64 baminercept 64 Vimpat R 64 plasma kallikrein inhibitor 64 Severe Sepsis 64 TEMSO 64 baseline LDH 64 CINQUIL 64 LymphoStat B 64 HIV coinfected 64 relapsed ALL 64 hereditary deficiency 64 lomitapide 64 paclitaxel eluting stents 64 Sebivo 64 corticosteroid dose 64 metastatic castration resistant 64 dalteparin 64 proguanil 64 clodronate 64 alicaforsen enema 64 fluticasone salmeterol 64 chronic ITP patients 64 Relapsing remitting MS 64 placebo controlled Phase 64 CAPHOSOL 64 urocortin 2 64 Phase IIA 64 CIPN 64 Acute Ischemic Stroke 64 DAVANAT 64 relapsed refractory multiple myeloma 64 cMET 64 statistically significant efficacy 64 ixabepilone 64 regorafenib 64 relapsing MS 64 Keppra ® 64 XELOX 64 Taxotere ® 64 plus methotrexate 64 MET amplification 64 decitabine 64 DU #b 64 IMA# 64 fosamprenavir 64 #mg BID [003] 64 gemcitabine carboplatin 64 virologic responses 64 formerly LymphoStat B 64 Tracleer R 64 apremilast 64 8mg/kg 64 sJIA 64 Hormone Refractory Prostate Cancer 64 recurrent glioma 64 Telintra 64 Campath alemtuzumab 64 Naive Patients 64 intravenous bisphosphonates 64 COMBIVIR 64 AVADO 64 Certolizumab pegol 64 dyslipidaemia 64 Seliciclib 64 Erythropoietic therapies may 64 darapladib 64 interferon ribavirin 64 Nilotinib 64 opioid induced bowel dysfunction 64 OPAXIO 64 Tyrima 64 Pertuzumab 64 heterozygous FH 64 oral renin inhibitor 64 R# #mg BID 64 GLYX 64 HGS ETR2 64 TMC# [002] 64 tolterodine ER 64 Ranolazine 64 SEBIVO 64 IFN beta 64 phase IIa clinical 64 trials RCTs 64 myopathy rhabdomyolysis 64 Pirfenidone 64 REMICADE ® 64 mg/m2 dose 64 basal bolus regimen 64 p# biomarker 64 baseline HbA1c 64 FACTIVE tablets 64 Raptiva R 64 nab paclitaxel 64 Talabostat 64 YONDELIS R 64 Afatinib 64 Glufosfamide 64 Neulasta ® 64 receiving VELCADE 64 PEG SN# 64 enoximone 64 ACTEMRA 64 symptomatic BPH 64 Viread Emtriva 64 Pazopanib 64 MGd 64 antiangiogenic activity 64 tenofovir disoproxil fumarate Viread 64 HuLuc# 64 TNF antagonist 64 virologic 64 GOUT 64 pharmacokinetic PK profile 64 cisplatin chemotherapy 64 Octreolin 64 biologic DMARD 64 Celsentri Selzentry 64 PSMA ADC 64 refractory CLL 64 Aryplase 64 HORIZONS AMI 64 mcg dose 64 Alvesco R 64 ACOMPLIA R 64 Microalbuminuria 64 Dabigatran etexilate 64 DAS# CRP 64 TORISEL 64 INTELENCE 64 Aclasta 64 tenofovir emtricitabine 64 Peginterferon alfa 2b 64 mesalamine granules 64 ZYVOX 64 naïve HCV 64 Dose Escalation 64 Tiotropium 64 Irinotecan 64 intensive lipid lowering 64 PRECiSE 64 psoriatic arthritis PsA 64 C1 INH deficiency 64 albiglutide 64 oropharyngeal candidiasis 64 #mg/day [001] 64 trabectedin 64 Rasilez Tekturna 64 concomitant medications 64 low dose cytarabine 64 chronic HBV 64 Valopicitabine 64 pramlintide metreleptin combination 64 LAF# 64 NAbs 64 Aptivus 64 pharmacodynamic effects 64 dosing frequency 64 HBeAg negative 64 TMC# C# 64 Tumor Response 64 IMiDs 64 subcutaneous PRO 64 Beta catenin pathway 64 Achieves Primary Endpoint 64 Boceprevir 64 lipid parameters 64 aldosterone antagonist 64 Reclast Aclasta 64 receiving golimumab 64 HER2 expression 64 Monotherapy 64 OXi# 64 RISPERDAL ® 64 gout flares 64 tipranavir ritonavir 64 Chronic Hepatitis C 64 enzastaurin 64 Diamyd r 64 rALLy clinical trial 64 -#.# log# copies mL 64 Prolongs Survival 64 cardiac toxicity 64 Phase #/#a trial 64 anti amnesic 64 MYDICAR 64 Lofexidine 64 Sandostatin LAR 64 generation NNRTI 64 GALNS 64 oral picoplatin 64 Thiovir 64 tigecycline 64 mitoxantrone plus 64 ruxolitinib 64 dose proportionality 64 ticagrelor Brilinta 64 IFN α 64 Gag polymorphisms 64 TNF Tumor Necrosis Factor 64 COMFORT II 64 HBeAg negative patients 64 relapsing remitting multiple sclerosis 64 elagolix 64 lumiracoxib 64 Pegasys ® 64 abiraterone acetate 64 Dapagliflozin 64 TRANSFORMS 64 Alinia 64 induced macular edema 64 AZILECT 64 gadobutrol 64 glycated hemoglobin levels 64 Increlex R 64 NOXAFIL 64 cinacalcet 64 5-FU/LV 64 NATRECOR ® 64 annualized relapse 64 Civacir 64 Edge STudy 64 DDP# 64 dexpramipexole 64 Velcade bortezomib 63 vismodegib 63 octreotide acetate 63 Tezampanel 63 uric acid lowering 63 pegfilgrastim 63 HCV protease inhibitors 63 MCyR 63 relapsed myeloma 63 RhuDex ® 63 β blockers 63 FOLOTYN ® 63 budesonide foam 63 epoetin beta 63 RLAI 63 ug dose 63 AVASTIN 63 Cladribine tablets 63 GABITRIL 63 Arixtra ® 63 Twinrix 63 PREZISTA rtv 63 ARCALYST ® 63 atazanavir ritonavir 63 MMX mesalamine 63 Folfox 63 Triolex 63 4mg/kg 63 #I TM# 63 CUSTOM III 63 Dual Opioid 63 Torisel 63 glycosylated hemoglobin HbA1c 63 vildagliptin 63 CCR5 receptor antagonist 63 mapatumumab 63 ExTRACT TIMI 63 demonstrated antitumor activity 63 Keppra R 63 oral diclofenac 63 FOLFOX6 63 Proellex TM 63 TO AVOID PREGNANCY WHILE 63 Cloretazine ® 63 #mg dose [001] 63 TELCYTA 63 macrolide antibiotic 63 plus prednisone prednisolone 63 Vicriviroc 63 ELOXATIN 63 BAL# [002] 63 viral kinetic 63 Tekamlo 63 pegylated liposomal doxorubicin 63 Tarceva erlotinib 63 Patients Treated With 63 nucleoside analog 63 glufosfamide 63 TREDAPTIVE 63 febuxostat 63 Toremifene 63 Phase 1b trial 63 Daclizumab 63 fosbretabulin 63 SCIg 63 Phase #/#a 63 ADHF 63 romiplostim 63 GRN# 63 dasatinib Sprycel 63 pegylated interferon alfa 2b 63 Valortim ® 63 bronchodilation 63 custirsen 63 Sitagliptin 63 Teriflunomide 63 RGB # 63 homozygous familial hypercholesterolemia 63 Cutaneous T 63 Keppra XR 63 virologic response 63 ELACYT 63 Quinamed 63 Mycophenolate Mofetil 63 metastatic hormone refractory 63 entecavir 63 CYPHER Stent 63 Lialda 63 azacitidine 63 tiotropium 63 PRoFESS 63 Phase 2a trial 63 refractory gout 63 Phase 1a clinical 63 G#DT 63 tramiprosate Alzhemed TM 63 tezampanel 63 afatinib 63 letrozole Femara 63 ® pioglitazone HCl 63 PrandiMet TM 63 Cimzia R 63 Ophena 63 NIASPAN 63 Advagraf 63 alemtuzumab Campath 63 antiepileptic drugs AEDs 63 docetaxel Taxotere 63 eculizumab therapy 63 Romiplostim 63 zonisamide SR 63 micafungin 63 FAMPYRA 63 eosinophilic asthma 63 Jevtana 63 CCR5 mAb 63 TAXOTERE ® 63 antiplatelet agent 63 Dyloject TM 63 VFEND 63 multicenter trials 63 torezolid phosphate 63 PSN# [002] 63 taxane refractory 63 Degarelix 63 LHON 63 venlafaxine Effexor 63 EOquin TM 63 mGluR5 NAM 63 aripiprazole Abilify 63 REBETOL combination therapy 63 BNC# 63 overt nephropathy 63 Dacogen injection 63 ZOSTAVAX 63 paclitaxel cisplatin 63 dopamine partial agonist 63 ACUITY trial 63 Phase IIb trials 63 ROTARIX 63 tipifarnib 63 anti EGFR antibody 63 bezafibrate 63 CMV disease 63 HER2 overexpression 63 INVIRASE 63 alpha 2a 63 venlafaxine XR 63 EndoTAG TM -1 63 heavily pretreated 63 Zavesca R 63 Adalimumab 63 kidney urologic 63 Copegus ribavirin 63 ENDEAVOR III 63 beta 1a 63 AAG geldanamycin analog 63 BRAF inhibitor 63 6R BH4 63 RSV hospitalizations 63 Doxil ® 63 PEGINTRON TM 63 Paraplatin ® 63 mycophenolate mofetil 63 rFIXFc 63 KRN# 63 PreCISe 63 fluvastatin 63 NLX P# 63 MAA submission 63 Phase #b/#a clinical 63 LCP Tacro ™ 63 boosted protease inhibitor 63 mg administered orally 63 AZT zidovudine Retrovir 63 CCyR 63 antitumor efficacy 63 herpetic keratitis 63 pramipexole 63 AZOR 63 Gabapentin GR 63 risedronate Actonel 63 PAOD 63 tolerability profile 63 Phase IIa trial 63 ONGLYZA 63 refractory chronic lymphocytic 63 AGILECT ® 63 antidiabetic drug 63 peginterferon alfa 63 metastatic GIST 63 Chronic HCV 63 Abbott HUMIRA 63 Trandolapril 63 alefacept 63 Tekturna HCT 63 infusional 5-FU/LV 63 mRCC 63 Hydroxyurea 63 SPRYCEL ® 63 Adjuvant Treatment 63 Fx #A 63 rindopepimut 63 Newly Diagnosed Multiple Myeloma 63 FOLPI regimen 63 QD dosing 63 telaprevir VX 63 CAMMS# 63 degarelix 63 TWYNSTA 63 atorvastatin #mg 63 demonstrated clinically meaningful 63 Zorbtive TM 63 ACR# responses 63 clinically meaningful improvement 63 irbesartan 63 ORMD 63 Panzem R 63 alfa 2a 63 CHAMPION PCI 63 paliperidone ER 63 smoldering multiple myeloma 63 induce remission 63 Antitumor Activity 63 Mylotarg 63 cIAI 63 LEXIVA 63 microbiological eradication 63 Mg Uk 63 nucleotide analogue 63 haematologic 63 Ilaris 63 Varespladib 63 ALGRX 63 adjunctive placebo 63 Triapine R 63 ritonavir boosted atazanavir 63 relapsed multiple myeloma 63 Ventavis 63 RANK Ligand inhibitor 63 ataluren 63 PREVENAR 63 Exacerbations 63 Interferon beta 63 nonvertebral fracture 63 GRNCM1 63 ARCALYST ® rilonacept 63 NeuroStar TMS Therapy 63 sustained virological response 63 rilpivirine 63 raloxifene Evista 63 ELND# 63 Raptiva r 63 Allovectin 7 ® 63 Capesaris 63 Panitumumab 63 TPV r 63 BoNTA 63 μg dose 63 Granulocyte Colony Stimulating Factor 63 SUTENT 63 talactoferrin 63 ABCSG 63 assessing T DM1 63 Pivotal Clinical Trial 63 Long Term Efficacy 63 relapsing multiple sclerosis 63 vicriviroc 63 #mg q8h 63 LIVALO 63 Omacetaxine 63 Targretin capsules 63 visilizumab 63 mildly symptomatic 63 glycosylated hemoglobin levels 63 ospemifene 63 metastatic malignant 63 Cloretazine 63 aplindore 63 Removab 63 retinal vein occlusion 63 HMG CoA reductase inhibitors 63 Pharmacokinetic parameters 63 oral Hycamtin 63 Lamictal XR 63 SORT OUT III 63 Relapsing Remitting Multiple Sclerosis 63 liposomal doxorubicin 63 evaluating Actimmune 63 Candesartan 63 NSABP C 63 relapsing forms 63 DP b# 63 Aliskiren 63 Ceflatonin 63 virus HCV protease inhibitor 63 calcineurin inhibitors 63 serum phosphorous 63 abatacept 63 low dose ritonavir 63 endometrial hyperplasia 63 Privigen 63 Bronchitol 63 DermaVir Patch 63 Phase IIB 63 XmAb# 63 teduglutide 63 TAXOTERE R 63 eszopiclone 63 Vidaza ® 63 ECTRIMS 63 Adefovir 63 brand ciclesonide HFA 63 INEGY 63 Procoralan 63 Darusentan 63 OAB symptoms 63 Q#IR 63 Intervention Effectiveness 63 Rilonacept 63 rFVIIa 63 poor metabolizers